Fulcrum Therapeutics, Inc. (FULC)
Data as of , from SEC Form 4 filings.
Net insider buying (90d)Watch FULC
See up to 3 months of FULC. The 7-day demo opens the 1M and 3M ranges and puts FULC on your watchlist.
Start 7-day demoLatest FULC insider trades
Kevin TangOpen-market purchase$415K- Kevin TangOpen-market purchase$179K
About Fulcrum Therapeutics, Inc. (FULC)
Fulcrum Therapeutics, Inc. is an SEC registrant, filing under CIK 0001680581, classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
FULC Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 2 | 167,616 | $595K |
FULC insider transactions (Form 4)
2622 Form 4 filings on record, the earliest from Nov 14, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Kevin Tang | Open-market purchase | Common Stock | 116,671 | $3.56 footnote F1 | $415K | |
| Kevin Tang | Open-market purchase | Common Stock | 50,945 | $3.52 footnote F3 | $179K | |
| ||||||
| Kevin Tang | Open-market purchase | Common Stock | 12,966 | $3.54 footnote F1 | $46K | |
| Kevin Tang | Open-market purchase | Common Stock | 53,651 | $3.56 footnote F3 | $191K | |
| Kevin Tang | Open-market purchase | Common Stock | 75,952 | $3.58 footnote F4 | $272K | |
| Kevin Tang | Open-market purchase | Common Stock | 107,377 | $3.56 footnote F5 | $382K | |
| ||||||
| Sonja Banks | Grant or award | Stock Option (right to buy) | 32,000 | $0.00 | - | |
| Katina Dorton | Grant or award | Stock Option (right to buy) | 32,000 | $0.00 | - | |
| Robert J. Gould | Grant or award | Stock Option (right to buy) | 32,000 | $0.00 | - | |
| Kate Haviland | Grant or award | Stock Option (right to buy) | 32,000 | $0.00 | - | |
| Rachel K. King | Grant or award | Stock Option (right to buy) | 32,000 | $0.00 | - | |
| James A. Geraghty | Grant or award | Stock Option (right to buy) | 32,000 | $0.00 | - | |
 Colin Hill | Grant or award | Stock Option (right to buy) | 32,000 | $0.00 | - | |
 Alan Ezekowitz | Grant or award | Stock Option (right to buy) | 32,000 | $0.00 | - | |
| Alan Ezekowitz | Open-market sale | Common Stock | 18,000 | $3.65 footnote F2 | $66K | |
| ||||||
| Joshua Lehrer-Graiwer | Grant or award | Stock Option (right to buy) | 64,000 | $0.00 | - | |
| Robert J. Gould | Open-market sale | Common Stock | 15,000 | $10.87 | $163K | |
 Alan A. Musso - Officer | Grant or award | Stock Option (right to buy) | 170,000 | $0.00 | - | |
| Curtis Gale Oltmans - Officer | Grant or award | Stock Option (right to buy) | 170,000 | $0.00 | - | |
| Greg Tourangeau - Officer | Grant or award | Stock Option (right to buy) | 57,000 | $0.00 | - | |
 Alex Sapir - Officer | Grant or award | Stock option - Right to Buy | 650,000 | $0.00 | - | |
| Robert J. Gould | Open-market sale | Common Stock | 15,000 | $11.87 | $178K | |
| Curtis Gale Oltmans - Officer | Open-market sale | Common Stock | 3,452 | $12.92 | $45K | |
| Robert J. Gould | Open-market sale | Common Stock | 15,000 | $11.03 footnote F2 | $165K | |
| ||||||
| James A. Geraghty | Grant or award | Stock Option (right to buy) | 36,000 | $0.00 | - | |
| Rachel K. King | Grant or award | Stock Option (right to buy) | 60,000 | $0.00 | - | |
Item 1.01, 3.02, 5.01, 5.02, 7.01, 9.01
Item 5.02
Item 5.07
Item 5.02
Recent FULC Form 144 notices of proposed sale
2An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Greg Tourangeau | former officer | 14,062 | $54K | View on EDGAR | |
| - | - | - | - |
FULC insider trading FAQ
What is the latest insider trade for FULC?
Fulcrum Therapeutics, Inc. (FULC) had 1 insider filing in the last 90 days, with the most recent on 2026-07-21. The full record for FULC runs to 22 Form 4 filings, the earliest from 2024-11-14. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying FULC stock?
2 insider purchases of FULC were filed in the last 90 days, totaling $595K.
How many insiders are selling FULC stock?
No insider sales of FULC were filed in the last 90 days. 5 sales are on record for this company.
Where can I see FULC SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects FULC Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Kevin Tang view on EDGAR
- - Kevin Tang view on EDGAR
- - Sonja Banks view on EDGAR
- - Katina Dorton view on EDGAR
- - Robert J. Gould view on EDGAR
- - Kate Haviland view on EDGAR
- - Rachel K. King view on EDGAR
- - James A. Geraghty view on EDGAR
- - Colin Hill view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where FULC's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow FULC with a 7-day demo
- FULC on your watchlist
- Every FULC Form 4 filing on record
- Up to 3 months of FULC price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
